Brightcove - BCOV Stock Forecast, Price & News

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Brightcove in the last twelve months. There are currently 2 hold ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" BCOV shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in BCOV, but not buy additional shares or sell existing shares.
View BCOV analyst ratings or view top-rated stocks.

2 analysts have issued 12-month price targets for Brightcove's shares. Their BCOV share price forecasts range from $8.00 to $9.00. On average, they expect the company's share price to reach $8.50 in the next year. This suggests a possible upside of 34.1% from the stock's current price.
View analysts price targets for BCOV or view top-rated stocks among Wall Street analysts.

Brightcove's stock was trading at $5.23 on January 1st, 2023. Since then, BCOV shares have increased by 21.2% and is now trading at $6.34.
View the best growth stocks for 2023 here.

The company is scheduled to release its next quarterly earnings announcement on Wednesday, February 15th 2023.
View our BCOV earnings forecast.

Brightcove Inc. (NASDAQ:BCOV) posted its quarterly earnings data on Tuesday, October, 26th. The software maker reported $0.05 earnings per share for the quarter, beating the consensus estimate of $0.02 by $0.03. The software maker earned $52.16 million during the quarter, compared to the consensus estimate of $50.94 million. Brightcove had a positive trailing twelve-month return on equity of 1.91% and a negative net margin of 1.49%. The company's quarterly revenue was up 6.3% compared to the same quarter last year. During the same period last year, the company earned $0.06 EPS.

Brightcove updated its fourth quarter 2022 earnings guidance on Wednesday, November, 9th. The company provided earnings per share (EPS) guidance of -$0.03-0 for the period, compared to the consensus EPS estimate of $0.05. The company issued revenue guidance of $49.20 million-$50.20 million, compared to the consensus revenue estimate of $53.20 million.

96 employees have rated Brightcove Chief Executive Officer Marc Debevoise on Glassdoor.com. Marc Debevoise has an approval rating of 84% among the company's employees. 93.0% of employees surveyed would recommend working at Brightcove to a friend.

Based on aggregate information from My MarketBeat watchlists, some companies that other Brightcove investors own include Energy Transfer (ET), Advanced Micro Devices (AMD), Ford Motor (F), OPKO Health (OPK), CBL & Associates Properties (CBL), Cypress Semiconductor (CY), Annaly Capital Management (NLY), AT&T (T), C3.ai (AI) and Ampio Pharmaceuticals (AMPE).

Brightcove trades on the NASDAQ under the ticker symbol "BCOV."

Brightcove's stock is owned by a variety of institutional and retail investors. Top institutional investors include AMH Equity Ltd (0.79%), Allspring Global Investments Holdings LLC (0.35%) and Concourse Financial Group Securities Inc. (0.00%). Insiders that own company stock include David Plotkin, Edenbrook Capital, Llc, Jeff Ray, Ritcha Ranjan, Thomas E Wheeler and Tsedal Neeley.
View institutional ownership trends.

Shares of BCOV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of BCOV stock can currently be purchased for approximately $6.34.

Brightcove (NASDAQ:BCOV) has a market capitalization of $266.72 million and generates $211.09 million in revenue each year. The software maker earns $5.40 million in net income (profit) each year or ($0.08) on an earnings per share basis.

The company employs 678 workers across the globe.

Brightcove's mailing address is 290 CONGRESS STREET, BOSTON MA, 02210. The official website for the company is www.brightcove.com. The software maker can be reached via phone at (617) 500-4947, via email at investorrelations@brightcove.com, or via fax at 617-261-4830.